About
Mission/Vision
Our Team
Board of Directors
Elite Members
Why Utah?
Life Sciences Report
Partnerships
Jobs
Membership
Why Join BioUtah?
Membership Prospectus
Apply for Membership
Member Login
Life Sciences Jobs
Member Discounts
Non-dilutive Funding
Membership Directory
Advocacy
News/Info
Biosphere Magazine
Life Sciences News
Reports/Publications
Podcasts
Events
Newsletter
About
Mission/Vision
Our Team
Board of Directors
Elite Members
Why Utah?
Life Sciences Report
Partnerships
Jobs
Membership
Why Join BioUtah?
Membership Prospectus
Apply for Membership
Member Login
Life Sciences Jobs
Member Discounts
Non-dilutive Funding
Membership Directory
Advocacy
News/Info
Biosphere Magazine
Life Sciences News
Reports/Publications
Podcasts
Events
Newsletter
Join Now
Utah Life Sciences News & Events
Corporate Policy and Infectious Disease Response Plan
March 25, 2020
Develop an overriding policy for how the company will respond to a COVID-19 outbreak and impacts. Helpful resources:
Click here
to download a copy of the World Health Organization’s guide to developing a “Strategic Preparedness and Response Plan for the New Coronavirus”
CDC Business and Employer Guidance
Implement a plan of action for counseling employees who are concerned they may have been exposed to the virus.
Identify an HR point of contact
Where to send them to get tested (
https://coronavirus.utah.gov.
)
Policy for self-quarantine
Tracing of exposure to others
Clarify PTO and sick leave policies to encourage employees who are not well to stay home. Paid sick leave should be adjusted to accommodate the response to COVID-19.
Understand that employees may be affected by school closures that will impact child care needs and employee availability.
Plan for business disruptions
Cross Train employees
Identify critical functions to maintain operations.
Examine supply chain vulnerabilities.
Establish a process to communicate information to employees on the company response plan
Coordination with state and local health officials is strongly suggested to ensure appropriate and timely actions and responses.
Recent News
Sethera Therapeutics Completes First Funding Round
Sorriso Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results for SOR102 in Ulcerative Colitis
CancerVax Passes First Test with Flying Colors
Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis
Here’s how Utah earned its No. 1 ranking for innovation
Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients